Korea Joongang Daily
Korea JoongAng Daily

GC Biopharma's Alyglo blood product headed to U.S.

The company's plant in Ochang, North Chungcheong is buzzing with the production of the blood product, the first by a Korean pharmaceutical to secure FDA approval.

2024-02-28

Indonesia's sovereign wealth fund to invest $50 million in SK Plasma's blood product plant

Indonesia’s sovereign wealth fund will invest up to $50 million into SK Plasma’s project to build a blood product plant in the country.

2023-10-10

SK Plasma to build $250 million plant in Jakarta

SK Plasma will build a $250 million blood-product plant in Jakarta, Indonesia.

2023-03-08

Korea's 'artificial sun' setting nuclear fusion records

A donut-shaped nuclear fusion reactor, 9 meters (30 feet) wide, 6 meters high and weighing 1,000 tons, welcomes visitors at the Korea Institute of Fusion Energy (KFE) in the central Korean city of Daejeon.

2023-02-24

Recovered Covid patient donates plasma for treatment 9 times

Cho Kyung-rae, a 32-year-old who completely recovered from Covid-19, is one such donor. As of his interview on Dec. 24, Cho had donated his plasma nine times, making him the biggest donor. He said, "I think it's a citizen's duty to participate in...

2021-02-08

Plasma donation

At the indoor sports stadium in Daegu on Monday, members of the Shincheonji Church of Jesus donate plasma to be used to develop cures for Covid-19. About 4,000 of the controversial religious sect's followers who have recovered from Covid-19...

2020-11-16

GC Pharma starts Phase 2 trials of Covid-19 plasma treatment

GC Pharma has started Phase 2 clinical trials for its Covid-19 treatment candidate, the company said Monday. 

2020-09-21

Daegu donors

Members of the Shincheonji Church of Jesus in Daegu participate in their second blood plasma donation clinic on Thursday at the Daegu Athletics Promotion Center in Suseong District, Daegu.

2020-08-27

Secret to treating Covid-19 could be in your blood

As the race to develop a Covid-19 treatment continues, a recent surge in blood donors among recovered patients has given momentum to the development of plasma-derived treatments with clinical trials set to start next month. As of Friday afternoon...

2020-06-22

Blood of Covid-19 survivors needed for research

The National Institute of Health and GC Pharma are struggling with a shortage of blood donations needed for the development a Covid-19 treatment that utilizes antibodies in the plasma.

2020-06-04